ArticleCancer science2018

Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients.

Bingyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.